Regeneron and Sanofi Announce FDA Approval of Dupixent for Chronic Spontaneous Urticaria in Patients Aged 12 and Older
18/4 17:20
Dupixent approved for chronic spontaneous urticaria in patients unresponsive to antihistamines, reducing itch and hives significantly....